tetO-MEF2C Citations (4)

Originally described in: Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success.
Addis RC, Ifkovits JL, Pinto F, Kellam LD, Esteso P, Rentschler S, Christoforou N, Epstein JA, Gearhart JD J Mol Cell Cardiol. 2013 Apr 13;60C:97-106. doi: 10.1016/j.yjmcc.2013.04.004. PubMed Journal

---

Articles Citing tetO-MEF2C

Articles
Inhibition of TGFbeta signaling increases direct conversion of fibroblasts to induced cardiomyocytes. Ifkovits JL, Addis RC, Epstein JA, Gearhart JD. PLoS One. 2014 Feb 26;9(2):e89678. doi: 10.1371/journal.pone.0089678. eCollection 2014. PubMed
Generation of a recombinant version of a biologically active cell-permeant human HAND2 transcription factor from E. coli. Haridhasapavalan KK, Sundaravadivelu PK, Joshi N, Das NJ, Mohapatra A, Voorkara U, Kaveeshwar V, Thummer RP. Sci Rep. 2022 Sep 27;12(1):16129. doi: 10.1038/s41598-022-19745-w. PubMed
Overexpression of GATA binding protein 4 and myocyte enhancer factor 2C induces differentiation of mesenchymal stem cells into cardiac-like cells. Razzaq SS, Khan I, Naeem N, Salim A, Begum S, Haneef K. World J Stem Cells. 2022 Sep 26;14(9):700-713. doi: 10.4252/wjsc.v14.i9.700. PubMed
Robust small molecule-aided cardiac reprogramming systems selective to cardiac fibroblasts. Tao Y, Yang Y, Yang Z, Wang L, Wang SQ, Zhao Y. iScience. 2023 Nov 14;26(12):108466. doi: 10.1016/j.isci.2023.108466. eCollection 2023 Dec 15. PubMed

If you have published an article using this material, please email us at to have your article added to this page.